CD151 and breast cancer: Because CD151 is associated with recurrence of basal-like breast cancer [31], it will be of interest to determine whether the CSC-associated role of CD151 is recapitulated by use of more clinically relevant PDX model of breast cancer under taxane-based regimens known to foster CSCs [157].